UnitedHealth Tries to Stop Lawsuits From Mom-And-Pop Drugstores
(Bloomberg) -- Hundreds of small, independent drugstores are accusing UnitedHealth Group Inc. of short-changing them by more than $100 million, and the health-care giant is trying to head off a lawsuit before it goes to court.
UnitedHealth's Optum Rx unit filed more than 200 legal cases this week in federal court in California to force the cases into individual arbitration processes, rather than allow a joint lawsuit to go forward, according to legal filings.
At least 1,000 independent U.S. pharmacies are challenging payment practices at Optum Rx, UnitedHealth's pharmacy benefits management unit that negotiates drug prices for health plans and companies, according to Mark Cuker, a lawyer representing the drugstores. About 500 are involved in the current dispute, while others have already filed cases in different courts. Making each of them enter arbitration is costly and limits the information they could gather through discovery, Cuker said.
“They want each of these pharmacies to have a separate arbitration, 500 separate arbitrations,” even though the pharmacies are raising common issues, Cuker said. Optum Rx is “gaming the system,” he said.
State courts have rejected other attempts to compel private arbitration over similar claims he's brought against Optum Rx, Cuker said.
“Optum Rx is focused on delivering affordable access to prescription drugs,” the company said in a statement. “The more than 67,000 retail pharmacies in Optum Rx's networks are important partners in these efforts, and we continue to work with them to balance the need to fairly compensate pharmacies while managing costs.”
The pharmacies involved in the cases say Optum Rx reimbursed them less than required and clawed back payments, according to UnitedHealth's filings. They also said Optum Rx sometimes called medications brand-named drugs when dealing with health plans but considered the same medicines lower-cost generics when paying pharmacies. Cuker estimated the total value of payments from Optum Rx that his clients are disputing exceeds $100 million over almost a decade.
Optum Rx received notice of the dispute from more than 500 pharmacies in December and said that the pharmacies' lawyer would only resolve the dispute in court. The pharmacies have not yet filed litigation against Optum Rx.
©2022 Bloomberg L.P.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.